Asymmetric Complementarity: A Subtype-Specific Strategy via Visual Assessment of DCE-MRI and DWI for Evaluating NAT Efficacy in Breast Cancer.
RATIONALE AND OBJECTIVES To evaluate dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging (DWI), based on clinical visual assessment for predicting pathological complete response (pCR) and measuring residual tumor size after neoadjuvant therapy (NAT) across breast cancer subtype...